The mechanism in inhibition of ovulation in oral contraception. II. The effect of PMS and HCG observed at laparotomy in patients treated with 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone ogether with 17-alpha-ethynyl-oestradiol-3-methylether.
D000328:Adult; D006063:Chorionic Gonadotropin / Q000494:pharmacology*; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004357:Drug Synergism; D005260:Female; D005640:Follicle Stimulating Hormone; D006064:Gonadotropins, Equine / Q000494:pharmacology*; D006801:Humans; D007986:Luteinizing Hormone; D008656:Mestranol / Q000494:pharmacology*; D010060:Ovulation / Q000187:drug effects*; D010902:Pituitary Gland / Q000187:drug effects; D011372:Progestins / Q000494:pharmacology*
D006063:Chorionic Gonadotropin; D003276:Contraceptives, Oral; D006064:Gonadotropins, Equine; D011372:Progestins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D008656:Mestranol